Crossmark

Screening the possible anti-cancer constituents of Hibiscus rosa-sinensis flower to address mammalian target of rapamycin: an in silico molecular docking, HYDE scoring, dynamic studies, and pharmacokinetic prediction

Crossref DOI link: https://doi.org/10.1007/s11030-022-10556-9

Published Online: 2022-11-01

Published Print: 2023-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Rasul, Hezha O. https://orcid.org/0000-0001-5250-003X
Aziz, Bakhtyar K.

Ghafour, Dlzar D.

Kivrak, Arif
License Information

Text and Data Mining valid from 2022-11-01

Version of Record valid from 2022-11-01
More Information

Article History

Received: 31 August 2022

Accepted: 24 October 2022

First Online: 1 November 2022

Declarations

:

: There are no conflicts of interest declared by the authors.

: This article does not contain any studied with human participants or animals performed by any of the authors.

Document is current

Any future updates will be listed below